The national health exhibition organizing committee selected the ASCENT project for the National Health Exhibition to present Digital Adherence Technology.
Philippine Business for Social Progress (PBSP) is stepping up the training of 180 programmatic management of drug-resistant tuberculosis (PMDT) nurses and regional technical staff across the Philippines.
Based on our experiences with implementing digital adherence technologies (DAT) at scale in five different contexts, we wrote a technical brief to highlight and summarize the ASCENT project implementation.
PBSP will expand the use of the smart pillbox for tuberculosis (TB) treatment in the Philippines. To jumpstart the scale-up, KNCV is providing technical support to PBSP.
Nugusse, who rides horse drawn carriages for a living in Ethiopia, successfully completed his tuberculosis (TB) treatment using a digital adherence technology (DAT), provided by the ASCENT project.
In this video, made in Ethiopia, Tsedale explains the advantages she experienced using a DAT, the medication sleeve/label, in comparison to DOT.
A first person account on how digital adherence technology can help reinforce medication adherence, in a way that benefits the patient and enhances health system efficiency.
ASCENT Philippines concludes digital adherence technology implementation activities; DAT scale-up assured in 2023
ASCENT concluded digital adherence technology (DAT) implementation activities in the Philippines. PBSP will expand DAT use nationwide.
The ASCENT project will phase out in December 2022. The Philippines, however, will expand the use of digital adherence technology across the country in 2023.
Video: How a digital adherence technology, the medication sleeve/label, helps a small-scale farmer from Tanzania
Meet Romana, a small scale farmer from Tanzania. She uses the medication sleeve/label to remind her to take her tuberculosis medication.